No headlines found.
Business Wire (Wed, 3-Dec 8:00 AM ET)
bioAffinity Technologies Reports Third Quarter 2025 Financial Results
Business Wire (Fri, 14-Nov 8:00 AM ET)
bioAffinity Technologies Reports Accelerating Month-Over-Month Growth in CyPath Lung Test Volume
Business Wire (Wed, 5-Nov 8:00 AM ET)
Business Wire (Tue, 28-Oct 8:00 AM ET)
bioAffinity Technologies Presents Research Supporting CyPath Lung Processing Methods at CHEST 2025
Business Wire (Mon, 20-Oct 8:00 AM ET)
Business Wire (Thu, 16-Oct 8:00 AM ET)
bioAffinity Technologies Regains Compliance with Nasdaq Listing Requirements
Business Wire (Wed, 15-Oct 8:00 AM ET)
Business Wire (Thu, 9-Oct 1:00 PM ET)
Business Wire (Wed, 8-Oct 3:45 PM ET)
bioAffinity Technologies Reports Record Growth in CyPath Lung Test Volume for Third Quarter 2025
Business Wire (Tue, 7-Oct 8:00 AM ET)
Bioaffinity Technologies - Warrant trades on the stock market under the symbol BIAFW.
As of December 19, 2025, BIAFW stock price was flat at $0.33 with million shares trading.
BIAFW has a market cap of $0.00. This is considered a Sub-Micro Cap stock.
In the last 3 years, BIAFW traded as high as $2.90 and as low as $.03.
BIAFW has underperformed the market in the last year with a return of -17.5%, while SPY returned +18.1%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in BIAFW shares. However, BIAFW has outperformed the market in the last 3 month and 2 week periods, returning +321.4% and +37.5%, while SPY returned +2.8% and -0.5%, respectively. This indicates BIAFW has been having a stronger performance recently.
BIAFW support price is $.29 and resistance is $.37 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BIAFW shares will trade within this expected range on the day.
